MicroTech Medical (Hangzhou) financials at a glance

+ Portfolio

The revenue of MicroTech Medical (Hangzhou) is reported as 0.2519 billion Dollars in the fiscal year 2023. The earnings were 0 Dollars per share in 2023, which was 66.67 higher than 2020. And about 0.019 billion Dollars are reported as free cash flow in the financials of MicroTech Medical (Hangzhou) 2023. No dividends were paid to the shareholders of the MicroTech Medical (Hangzhou) stock SEHK:2235 in the financial year 2023.

Forecast

Financials

Year	Year	TTM	2021	2020
Rev.	Revenue	N/A	HK$151.40M	HK$75.28M
GM %	Gross Margin %	49.64%	46.82%	0.00%
OM	Operating Margin	-77.53%	-39.74%	0.00%
EPS	Earnings Per Share	HK$-0.11	HK$-0.13	HK$-0.39
Div.	Dividends	N/A	HK$0.00	HK$0.00
PR %	Payout Ratio %	0	-0.00%	0
Sha.	Shares	N/AM	425.74M	360M
OCF	Operating Cash Flow	N/A	HK$-44.22M	HK$0.00M
FCF	Free Cash Flow	N/A	HK$-61.82M	HK$0.00M
FCFS	Free Cash Flow Per Share	HK$-0.31	HK$-0.17	HK$0.00

MicroTech Medical (Hangzhou) financials at a glance

Financials

Discover